Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6529771rdf:typepubmed:Citationlld:pubmed
pubmed-article:6529771lifeskim:mentionsumls-concept:C0039854lld:lifeskim
pubmed-article:6529771lifeskim:mentionsumls-concept:C0279516lld:lifeskim
pubmed-article:6529771lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6529771lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:6529771pubmed:issue3lld:pubmed
pubmed-article:6529771pubmed:dateCreated1985-4-29lld:pubmed
pubmed-article:6529771pubmed:abstractTextThis in vitro study of thiamphenicol activity against 247 strains of Gram-positive and 195 strains of Gram-negative pathogenic bacteria showed no significant changes from past activity. Of the 442 strains involved, thiamphenicol proved: - Effective (MIC = less than or equal to 0.5-4 micrograms/ml) against 131 strains, mostly streptococci, pneumococci and enterococci. - Moderately effective (MIC = 8-64 micrograms/ml) against 252 strains, mostly staphylococci, Salmonella, Citrobacter, K. pneumoniae, Enterobacter, E. coli and Proteus. - Ineffective (MIC = 64 micrograms/ml) against 59 strains, mostly Proteus, E. coli and K. pneumoniae. Against 23 strains of Neisseria gonorrhoeae, thiamphenicol generally proved as effective as penicillin G and cefuroxime and more effective than spectinomycin.lld:pubmed
pubmed-article:6529771pubmed:languageenglld:pubmed
pubmed-article:6529771pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6529771pubmed:citationSubsetIMlld:pubmed
pubmed-article:6529771pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6529771pubmed:statusMEDLINElld:pubmed
pubmed-article:6529771pubmed:monthJunlld:pubmed
pubmed-article:6529771pubmed:issn0392-906Xlld:pubmed
pubmed-article:6529771pubmed:authorpubmed-author:CarenziAAlld:pubmed
pubmed-article:6529771pubmed:authorpubmed-author:PerettiPPlld:pubmed
pubmed-article:6529771pubmed:authorpubmed-author:MancaNNlld:pubmed
pubmed-article:6529771pubmed:authorpubmed-author:RavizzolaGGlld:pubmed
pubmed-article:6529771pubmed:issnTypePrintlld:pubmed
pubmed-article:6529771pubmed:volume3lld:pubmed
pubmed-article:6529771pubmed:ownerNLMlld:pubmed
pubmed-article:6529771pubmed:authorsCompleteYlld:pubmed
pubmed-article:6529771pubmed:pagination163-6lld:pubmed
pubmed-article:6529771pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:6529771pubmed:meshHeadingpubmed-meshheading:6529771-...lld:pubmed
pubmed-article:6529771pubmed:meshHeadingpubmed-meshheading:6529771-...lld:pubmed
pubmed-article:6529771pubmed:meshHeadingpubmed-meshheading:6529771-...lld:pubmed
pubmed-article:6529771pubmed:meshHeadingpubmed-meshheading:6529771-...lld:pubmed
pubmed-article:6529771pubmed:year1984lld:pubmed
pubmed-article:6529771pubmed:articleTitleIn vitro antibacterial activity of thiamphenicol.lld:pubmed
pubmed-article:6529771pubmed:publicationTypeJournal Articlelld:pubmed